
Sponsored
Russell Miller, SVP of Global Sales and Marketing at Enzene, explains why he believes biologics manufacturing is at an inflection point as the industry moves beyond decades of fed-batch processing.

Sponsored
Russell Miller, SVP of Global Sales and Marketing at Enzene, explains why he believes biologics manufacturing is at an inflection point as the industry moves beyond decades of fed-batch processing.

Sponsored
Discover how Enzene is bringing next-generation continuous manufacturing technology directly to biopharma facilities.

Sponsored Content
Innovative Fully-Connected Continuous Manufacturing™ technology and advanced facilities are revolutionizing biomanufacturing and driving cost efficiency, especially in monoclonal antibody production.